Israeli company, Nano Dimensions has just announced it is to create a subsidiary that will focus on developing solutions for End Stage Renal Disease. You can read the full story here.
The US Food and Drug Administration has approved a new treatment for secondary hyperparathyroidism which is administered at the end of a dialysis session. See the link below for the full story. FDA approves new treatment for secondary hyperparathyroidism
If you’re planning an event for World Kidney Day this year please see the document below for information and details of how to obtain event materials. You can also view/download the document here.